Emre S - Search Results

1

Roux-en-Y anastomotic bleeding following orthotopic liver transplantation: experience in our first 300 patients.

Mor E, Borcich A, Shwersenz A, Berner J, Katz E, Emre S, Schwartz M, Miller C. Mor E, et al. Among authors: emre s. Transplant Proc. 1993 Apr;25(2):1925-6. Transplant Proc. 1993. PMID: 8470229 No abstract available.

2

Orthotopic hepatic transplantation in the dog.

Emre S, Sumrani N, Youngelman D, Ding Z, Davis R, Hong JH. Emre S, et al. J Invest Surg. 1992 Jan-Mar;5(1):51-9. doi: 10.3109/08941939209031593. J Invest Surg. 1992. PMID: 1576106 Free article.

3

Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients.

Mor E, Schwersenz A, Sheiner PA, Emre S, Schwartz ME, Miller CM. Mor E, et al. Among authors: emre s. Transplantation. 1994 Apr 15;57(7):1130-2. Transplantation. 1994. PMID: 7513098 No abstract available.

4

Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506.

Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM. Sheiner PA, et al. Among authors: emre s. Transplantation. 1994 Apr 15;57(7):1132-3. Transplantation. 1994. PMID: 7513099 No abstract available.

5

Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506.

Jindal RM, Popescu I, Emre S, Schwartz ME, Boccagni P, Meneses P, Mor E, Sheiner P, Miller CM. Jindal RM, et al. Among authors: emre s. Transplantation. 1994 May 15;57(9):1395-8. doi: 10.1097/00007890-199405150-00020. Transplantation. 1994. PMID: 7514317 Clinical Trial. No abstract available.

6

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.

Jindal RM, Popescu I, Schwartz ME, Emre S, Boccagni P, Miller CM. Jindal RM, et al. Among authors: emre s. Transplantation. 1994 Aug 15;58(3):370-2. Transplantation. 1994. PMID: 7519799 Clinical Trial. No abstract available.

7

Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression.

Mor E, Sheiner PA, Schwartz ME, Emre S, Guy S, Miller CM. Mor E, et al. Among authors: emre s. Transplantation. 1994 Aug 15;58(3):380-2. Transplantation. 1994. PMID: 7519800 No abstract available.

8

Gastrointestinal toxicity associated with FK 506 in liver transplant recipients.

Fisher A, Schwartz M, Mor E, Sheiner P, Emre S, Guy S, Miller C. Fisher A, et al. Among authors: emre s. Transplant Proc. 1994 Dec;26(6):3106-7. Transplant Proc. 1994. PMID: 7527947 Clinical Trial. No abstract available.

9

Immunosuppression conversion for relief of side effects.

Guy S, Mor E, Fisher A, Schwartz M, Sheiner P, Emre S, Miller C. Guy S, et al. Among authors: emre s. Transplant Proc. 1994 Dec;26(6):3235-6. Transplant Proc. 1994. PMID: 7527956 No abstract available.

10

Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.

Mor E, Facklam D, Hasse J, Sheiner P, Emre S, Schwartz M, Miller C. Mor E, et al. Among authors: emre s. Transplant Proc. 1995 Feb;27(1):1126. Transplant Proc. 1995. PMID: 7533363 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters